Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inflectra
Pharma
Pfizer, Johnson & Johnson settle high-profile biosimilars case
Pfizer and Johnson & Johnson reached a settlement over their high-profile biosimilar lawsuit dating back to 2017.
Kevin Dunleavy
Jul 26, 2021 11:20am
Pfizer, Amgen entering 'golden age' for biosimilars: analyst
Aug 5, 2020 9:50am
J&J's fight against Remicade biosims draws FTC scrutiny
Jul 30, 2019 11:51am
Remicade, biosim prices slip as competition heats up: analyst
Dec 11, 2018 11:19am
Pfizer rolls out Retacrit at big discount to Amgen, J&J drugs
Nov 14, 2018 11:56am
Merck wins national VA contract for its Remicade biosimilar
Oct 8, 2018 11:12am
